rs113571700

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_153717.3(EVC):​c.385-16C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00626 in 1,599,726 control chromosomes in the GnomAD database, including 114 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.010 ( 22 hom., cov: 31)
Exomes 𝑓: 0.0058 ( 92 hom. )

Consequence

EVC
NM_153717.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0660
Variant links:
Genes affected
EVC (HGNC:3497): (EvC ciliary complex subunit 1) This gene encodes a protein containing a leucine zipper and a transmembrane domain. This gene has been implicated in both Ellis-van Creveld syndrome (EvC) and Weyers acrodental dysostosis. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 4-5731409-C-T is Benign according to our data. Variant chr4-5731409-C-T is described in ClinVar as [Benign]. Clinvar id is 262781.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.0104 (1582/151908) while in subpopulation SAS AF= 0.0308 (147/4772). AF 95% confidence interval is 0.0267. There are 22 homozygotes in gnomad4. There are 805 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 22 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EVCNM_153717.3 linkc.385-16C>T intron_variant Intron 3 of 20 ENST00000264956.11 NP_714928.1 P57679

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EVCENST00000264956.11 linkc.385-16C>T intron_variant Intron 3 of 20 1 NM_153717.3 ENSP00000264956.6 P57679
EVCENST00000509451.1 linkc.385-16C>T intron_variant Intron 3 of 11 1 ENSP00000426774.1 E9PCN4

Frequencies

GnomAD3 genomes
AF:
0.0104
AC:
1574
AN:
151790
Hom.:
22
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0245
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00551
Gnomad ASJ
AF:
0.00894
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0308
Gnomad FIN
AF:
0.0000946
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.00390
Gnomad OTH
AF:
0.0120
GnomAD3 exomes
AF:
0.00821
AC:
2045
AN:
249028
Hom.:
30
AF XY:
0.00931
AC XY:
1255
AN XY:
134826
show subpopulations
Gnomad AFR exome
AF:
0.0249
Gnomad AMR exome
AF:
0.00385
Gnomad ASJ exome
AF:
0.0127
Gnomad EAS exome
AF:
0.000218
Gnomad SAS exome
AF:
0.0271
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00450
Gnomad OTH exome
AF:
0.00655
GnomAD4 exome
AF:
0.00582
AC:
8425
AN:
1447818
Hom.:
92
Cov.:
30
AF XY:
0.00654
AC XY:
4715
AN XY:
721288
show subpopulations
Gnomad4 AFR exome
AF:
0.0287
Gnomad4 AMR exome
AF:
0.00398
Gnomad4 ASJ exome
AF:
0.0112
Gnomad4 EAS exome
AF:
0.000151
Gnomad4 SAS exome
AF:
0.0282
Gnomad4 FIN exome
AF:
0.000487
Gnomad4 NFE exome
AF:
0.00357
Gnomad4 OTH exome
AF:
0.00843
GnomAD4 genome
AF:
0.0104
AC:
1582
AN:
151908
Hom.:
22
Cov.:
31
AF XY:
0.0108
AC XY:
805
AN XY:
74224
show subpopulations
Gnomad4 AFR
AF:
0.0247
Gnomad4 AMR
AF:
0.00550
Gnomad4 ASJ
AF:
0.00894
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.0308
Gnomad4 FIN
AF:
0.0000946
Gnomad4 NFE
AF:
0.00390
Gnomad4 OTH
AF:
0.0119
Alfa
AF:
0.00791
Hom.:
1
Bravo
AF:
0.0111
Asia WGS
AF:
0.0170
AC:
58
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Aug 01, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:2
Oct 16, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome Benign:1
Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ellis-van Creveld syndrome Benign:1
Jun 15, 2021
Pars Genome Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
0.82
DANN
Benign
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs113571700; hg19: chr4-5733136; API